Wed, September 4, 2024
Tue, September 3, 2024
Fri, August 30, 2024
Thu, August 29, 2024
Wed, August 28, 2024

Sumant Kulkarni Maintained (BTAI) at Strong Buy and Held Target at $7 on, Aug 30th, 2024


//stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-7-on-aug-30th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $7 on, Aug 30th, 2024.

Sumant has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 1 agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $1 on, Friday, August 9th, 2024


This is the rating of the analyst that currently disagrees with Sumant


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Thursday, August 8th, 2024

Publication Contributing Sources